Biblioteca Hospital 12 de Octubre
Vista normal Vista MARC Vista ISBD

IPSCs, a Promising Tool to Restore Muscle Atrophy. [artículo]

Por: Pareja Galeano, Helios [Instituto de Investigación imas12] | Sanchis Gomar, Fabián [Instituto de Investigación imas12] | Gallardo, María Esther [Instituto de Investigación i+12] | Lucía, Alejandro [Instituto de Investigación i+12].
Colaborador(es): Instituto de Investigación imas12.
Tipo de material: materialTypeLabelArtículoEditor: Journal of cellular physology, 2016Descripción: 231(2):259-60.Recursos en línea: Solicitar documento Resumen: Induced pluripotent stem cells (iPSCs) are a promising tool for regenerative medicine in chronic conditions associated with muscle atrophy since iPSCs are easier to obtain, pose less ethical limitations and can better capture human genetic diversity compared with human embryonic stem cells. We highlight the potentiality of iPSCs for treating muscle-affecting conditions for which no effective cure is yet available, notably aging sarcopenia and inherited neurometabolic conditions. J. Cell. Physiol. 231: 259-260, 2016.
Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Ingresar para agregar etiquetas.
    valoración media: 0.0 (0 votos)

Formato Vancouver:
Pareja Galeano H, Sanchís Gomar F, Emanuele E, Gallardo ME, Lucía A. IPSCs, a Promising Tool to Restore Muscle Atrophy. J Cell Physiol. 2016 Feb;231(2):259-60.

PMID: 26224204

Contiene 12 referencias

Induced pluripotent stem cells (iPSCs) are a promising tool for regenerative medicine in chronic conditions associated with muscle atrophy since iPSCs are easier to obtain, pose less ethical limitations and can better capture human genetic diversity compared with human embryonic stem cells. We highlight the potentiality of iPSCs for treating muscle-affecting conditions for which no effective cure is yet available, notably aging sarcopenia and inherited neurometabolic conditions. J. Cell. Physiol. 231: 259-260, 2016.

No hay comentarios para este ejemplar.

Ingresar a su cuenta para colocar un comentario.

Con tecnología Koha